Natixis Investment Managers International Eli Lilly & CO Transaction History

Natixis Investment Managers International

$1.39 Billion
Q3 2024

A detailed history of Natixis Investment Managers International transactions in Eli Lilly & CO stock. As of the latest transaction made, Natixis Investment Managers International holds 117,911 shares of LLY stock, worth $88.2 Million. This represents 7.53% of its overall portfolio holdings.

Number of Shares

117,911

Previous 121,792 3.19%

Holding current value

$88.2 Million

Previous $110 Million 5.27%

% of portfolio

7.53%

Previous 8.25%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $3 Million - $3.73 Million	-3,881 Reduced 3.19%	117,911 $104 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $3.86 Million - $4.84 Million	5,324 Added 4.57%	121,792 $110 Million
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $112,518 - $150,533	190 Added 0.16%	116,468 $90.6 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $23,108 - $27,241	44 Added 0.04%	116,278 $67.8 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $104,762 - $144,431	-241 Reduced 0.21%	116,234 $62.4 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $3.43 Million - $4.59 Million	9,787 Added 9.17%	116,475 $54.6 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $204,394 - $240,051	-658 Reduced 0.61%	106,688 $36.6 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $795,193 - $926,558	-2,473 Reduced 2.25%	107,346 $39.3 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $153 Million - $175 Million	-517,143 Reduced 82.48%	109,819 $35.9 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $4.79 Million - $5.63 Million	17,196 Added 2.82%	626,962 $203 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $120 Million - $149 Million	510,552 Added 514.6%	609,766 $175 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $224,850 - $279,040	-1,000 Reduced 1.0%	99,214 $27.5 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $107,919 - $132,809	-487 Reduced 0.48%	100,214 $23.3 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $1.35 Million - $1.74 Million	7,454 Added 7.99%	100,701 $23.2 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $1.33 Million - $1.72 Million	8,097 Added 9.51%	93,247 $17.3 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $80,885 - $107,030	-620 Reduced 0.72%	85,150 $14.2 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $24,857 - $28,752	-170 Reduced 0.2%	85,770 $12.6 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $3.39 Million - $4.08 Million	24,850 Added 40.68%	85,940 $14 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $369,055 - $456,785	-3,100 Reduced 4.83%	61,090 $8.37 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $444,787 - $550,908	-4,160 Reduced 6.09%	64,190 $8.42 Million
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $92,907 - $101,059	-870 Reduced 1.26%	68,350 $7.68 Million
Q2 2019 Aug 13, 2019	BUY	$110.79 - $129.32 $1.18 Million - $1.37 Million	10,610 Added 18.1%	69,220 $7.74 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $47,863 - $56,338	-430 Reduced 0.73%	58,610 $7.56 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $1.99 Million - $2.23 Million	-18,797 Reduced 24.15%	59,040 $6.75 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $808,887 - $1.01 Million	-9,421 Reduced 10.8%	77,837 $8.32 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $771,685 - $885,654	-10,194 Reduced 10.46%	87,258 $7.52 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $2.93 Million - $3.46 Million	39,472 Added 68.08%	97,452 $7.55 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $1.13 Million - $1.22 Million	-13,832 Reduced 19.26%	57,980 $4.94 Million
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $350,514 - $389,035	-4,548 Reduced 5.96%	71,812 $6.12 Million
Q2 2017 Aug 14, 2017	BUY	N/A	76,360	76,360 $6.33 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Investment Managers International, based on Form 13F filings with the SEC.

News

Stay updated on Natixis Investment Managers International with notifications on news.

Account

Natixis Investment Managers International Eli Lilly & CO Transaction History